Company Filing History:
Years Active: 2017-2022
Title: Gregory Hoffman: Innovator in Cancer Treatment
Introduction
Gregory Hoffman is a notable inventor based in Cambridge, MA, who has made significant contributions to the field of cancer treatment. With a focus on personalized therapies, his work aims to improve the lives of patients battling cancer. He holds 2 patents that reflect his innovative approach to medical science.
Latest Patents
Hoffman's latest patents include groundbreaking inventions such as "Compositions and methods to treat cancer." This patent discloses novel personalized therapies, kits, transmittable forms of information, and methods for treating patients with cancer, particularly those amenable to therapeutic treatment with inhibitors. Additionally, he has developed a patent titled "Biomarkers associated with BRM inhibition," which provides methods for detecting cancer biomarkers, including mutations in the SWI/SNF complex. This invention aims to determine a cancer subject's suitability for treatment with BRM inhibitors.
Career Highlights
Gregory Hoffman is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to collaborate with other experts in the field, further enhancing his contributions to cancer research and treatment.
Collaborations
Some of Hoffman's notable coworkers include Frank Peter Stegmeier and Eric Billy, who share his commitment to advancing cancer therapies.
Conclusion
Gregory Hoffman is a distinguished inventor whose work in cancer treatment is paving the way for innovative therapies. His patents and collaborations reflect a dedication to improving patient outcomes in the fight against cancer.